Is Adjuvant Chemotherapy Beneficial to All Patients With pT3N0M0 Stage Gastric Cancer?

BACKGROUND: The efficacy and benefits of adjuvant chemotherapy (AC) for patients with gastric cancer pT3N0M0 remain controversial. METHODS: We prospectively collected and retrospectively analyzed 235 patients with pT3N0M0 gastric cancer who underwent radical resection between February 2010 and Janua...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Jiao-Bao, Lu, Jun, Wu, Dong, Xu, Bin-bin, Xue, Zhen, Lin, Guo-Sheng, Zheng, Hua-Long, Shen, Li-li, Lin, Jia, Xie, Jian-Wei, Wang, Jia-Bin, Lin, Jian-Xian, Chen, Qi-Yue, Cao, Long-Long, Zheng, Chao-Hui, Huang, Chang-Ming, Li, Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8428976/
https://www.ncbi.nlm.nih.gov/pubmed/34513692
http://dx.doi.org/10.3389/fonc.2021.712432

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8428976/
https://www.ncbi.nlm.nih.gov/pubmed/34513692
http://dx.doi.org/10.3389/fonc.2021.712432

Ejemplares similares